Aimmune Therap (NQ: AIMT )

34.49 USD UNCHANGED

Last Price Updated: 7:11 PM EDT, Oct 12, 2020 Add to My Watchlist

Price and Volume

Volume	0
Open	34.49
Bid (Size)	34.46 (250)
Ask (Size)	34.51 (2)
Prev. Close	34.49
Today's Range	34.49 - 34.49
52wk Range	10.09 - 34.59
Shares Outstanding	58,095,408
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm

November 19, 2020

Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aimmune Therapeutics, Inc. In The Northern District Of California

October 15, 2020

Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Northern District of California, Case No. 4:20-cv-06733-YGR, on...

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	+0.94%	+0.94%
1 Year	+67.35%	+67.35%

More News

Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.

October 13, 2020

Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation

October 02, 2020

Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years

February 25, 2021

Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies

September 23, 2020

MERGER INVESTIGATION ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – MNTA, VRTU, AIMT, MXIM

September 20, 2020

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aimmune Therapeutics, Inc. - AIMT

September 18, 2020

ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm

September 17, 2020

Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc

September 16, 2020

Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation

October 02, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.